Compounds > 2-amino-5-phosphonovalerate
Page last updated: 2024-10-21

2-amino-5-phosphonovalerate and Pain, Chronic

2-amino-5-phosphonovalerate has been researched along with Pain, Chronic in 1 studies

2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Aubrey, KR1
Sheipouri, D1
Balle, T1
Vandenberg, RJ1
Otsu, Y1

Other Studies

1 other study available for 2-amino-5-phosphonovalerate and Pain, Chronic

ArticleYear
Glutamate, d-(-)-2-Amino-5-Phosphonopentanoic Acid, and
    Molecular pharmacology, 2020, Volume: 98, Issue:6

    Topics: 2-Amino-5-phosphonovalerate; Animals; Buffers; Cells, Cultured; Chronic Pain; Glutamic Acid; Humans;

2020